Robert Bessler - 12 Dec 2025 Form 4 Insider Report for LifeStance Health Group, Inc. (LFST)

Role
Director
Signature
By: /s/ Ryan Pardo, Attorney-in-Fact
Issuer symbol
LFST
Transactions as of
12 Dec 2025
Net transactions value
-$644,803
Form type
4
Filing time
16 Dec 2025, 19:49:53 UTC
Previous filing
13 Jun 2025
Next filing
19 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bessler Robert Director C/O LIFESTANCE HEALTH GROUP, INC., 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE By: /s/ Ryan Pardo, Attorney-in-Fact 16 Dec 2025 0001864881

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFST Common Stock Sale $279,103 -39,815 -2.8% $7.01 1,382,175 12 Dec 2025 Vitthal LLC F1, F2
transaction LFST Common Stock Sale $279,103 -39,815 -2.6% $7.01 1,498,975 12 Dec 2025 Shama LLC F1, F3
transaction LFST Common Stock Sale $43,302 -6,186 -0.45% $7.00 1,375,989 15 Dec 2025 Vitthal LLC F2, F4
transaction LFST Common Stock Sale $43,295 -6,185 -0.41% $7.00 1,492,790 15 Dec 2025 Shama LLC F3, F4
holding LFST Common Stock 57,619 12 Dec 2025 Direct
holding LFST Common Stock 36,363 12 Dec 2025 See Footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.045 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act of 1934 (the "Exchange Act") or for any other purpose.
F3 The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.01 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 Shares held of record by Alpine Glow Capital. The Reporting Person is the manager and sole member of Alpine Glow Capital. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.